Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Begins ‘Soft’ TAP, Will Phase In Pilot Over Five Years

Executive Summary

The US Food and Drug Administration has rolled out a program designed to speed up the development of innovative medical devices. The Total Product Lifecycle Advisory Program pilot was authorized under MDUFA V.

You may also be interested in...

Researchers Propose TPLC Framework For AI/ML Devices To Promote Health Equity

Researchers from the University of Iowa proposed a framework for a total product life cycle approach to addressing bias in AI/ML devices.

FDA To Expand TAP Pilot Program

The US Food and Drug Administration is set to expand a pilot program aimed at speeding up the development of innovative medical devices. The agency will begin enrolling more devices in the Total Product Lifecycle Advisory Program, which the agency rolled out in January.

Device Recalls Up, Manufacturing Defects Called The Culprit

Medical device recalls have ticked up this year because of defects in manufacturing, according to a report from Sedgwick.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts